These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


541 related items for PubMed ID: 27476837

  • 21. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
    Santoni M, Conti A, Partelli S, Porta C, Sternberg CN, Procopio G, Bracarda S, Basso U, De Giorgi U, Derosa L, Rizzo M, Ortega C, Massari F, Iacovelli R, Milella M, Di Lorenzo G, Buti S, Cerbone L, Burattini L, Montironi R, Santini D, Falconi M, Cascinu S.
    Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
    [Abstract] [Full Text] [Related]

  • 22. Outcomes and effectiveness of posterior occipitocervical fusion for suboccipital spinal metastases.
    Luksanapruksa P, Buchowski JM, Wright NM, Valone FH, Peters C, Bumpass DB.
    J Neurosurg Spine; 2017 May; 26(5):554-559. PubMed ID: 28291404
    [Abstract] [Full Text] [Related]

  • 23. Factors Affecting Survival in Patients Undergoing Palliative Spine Surgery for Metastatic Lung and Hepatocellular Cancer: Dose the Type of Surgery Influence the Surgical Results for Metastatic Spine Disease?
    Ha KY, Kim YH, Ahn JH, Park HY.
    Clin Orthop Surg; 2015 Sep; 7(3):344-50. PubMed ID: 26330957
    [Abstract] [Full Text] [Related]

  • 24. Surgical management of primary and metastatic sarcoma of the mobile spine.
    Rao G, Suki D, Chakrabarti I, Feiz-Erfan I, Mody MG, McCutcheon IE, Gokaslan Z, Patel S, Rhines LD.
    J Neurosurg Spine; 2008 Aug; 9(2):120-8. PubMed ID: 18764743
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [Abstract] [Full Text] [Related]

  • 28. Patient survival after surgery for osseous metastases from renal cell carcinoma.
    Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW.
    J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
    [Abstract] [Full Text] [Related]

  • 29. Metastatic Renal Cell Carcinoma to the Spine: Outcomes and Morbidity: Single-Center Experience.
    Park BJ, Seaman SC, Noeller JL, Smith MC, Hasan DM, Yasin H, Hitchon PW.
    World Neurosurg; 2021 Oct; 154():e398-e405. PubMed ID: 34280537
    [Abstract] [Full Text] [Related]

  • 30. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma.
    Higuchi T, Yamamoto N, Hayashi K, Takeuchi A, Abe K, Taniguchi Y, Kato S, Murakami H, Tsuchiya H.
    Bone Joint J; 2018 Sep; 100-B(9):1241-1248. PubMed ID: 30168767
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Factors affecting survival in 43 consecutive patients after surgery for spinal metastases from thyroid carcinoma.
    Sellin JN, Suki D, Harsh V, Elder BD, Fahim DK, McCutcheon IE, Rao G, Rhines LD, Tatsui CE.
    J Neurosurg Spine; 2015 Oct; 23(4):419-28. PubMed ID: 26140400
    [Abstract] [Full Text] [Related]

  • 33. An analysis of tumor-related potential spinal column instability (Spine Instability Neoplastic Scores 7-12) eventually requiring surgery with a 1-year follow-up.
    Vargas E, Lockney DT, Mummaneni PV, Haddad AF, Rivera J, Tan X, Jamieson A, Mahmoudieh Y, Berven S, Braunstein SE, Chou D.
    Neurosurg Focus; 2021 May; 50(5):E6. PubMed ID: 33932936
    [Abstract] [Full Text] [Related]

  • 34. Surgical treatment of sacral metastases: indications and results.
    Feiz-Erfan I, Fox BD, Nader R, Suki D, Chakrabarti I, Mendel E, Gokaslan ZL, Rao G, Rhines LD.
    J Neurosurg Spine; 2012 Oct; 17(4):285-91. PubMed ID: 22900506
    [Abstract] [Full Text] [Related]

  • 35. [Surgical treatment and prognosis factors in spinal metastases of breast cancer].
    Ulmar B, Richter M, Cakir B, Brunner A, Puhl W, Huch K.
    Z Orthop Ihre Grenzgeb; 2005 Oct; 143(2):186-94. PubMed ID: 15849638
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Surgical treatment indications and outcomes in patients with spinal metastases in the cervicothoracic junction (CTJ).
    Li Z, Long H, Guo R, Xu J, Wang X, Cheng X, Huang Y, Li F.
    J Orthop Surg Res; 2018 Jan 30; 13(1):20. PubMed ID: 29382354
    [Abstract] [Full Text] [Related]

  • 38. Outcomes following surgical intervention for impending and gross instability caused by multiple myeloma in the spinal column.
    Zadnik PL, Goodwin CR, Karami KJ, Mehta AI, Amin AG, Groves ML, Wolinsky JP, Witham TF, Bydon A, Gokaslan ZL, Sciubba DM.
    J Neurosurg Spine; 2015 Mar 30; 22(3):301-9. PubMed ID: 25575166
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE.
    Eur Urol; 2005 Jul 30; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.